NCT06019338 is a clinical trial of Pain Diary use in Trigeminal Neuralgia, sponsored by Noema Pharma AG.

Who is sponsoring NCT06019338?

NCT06019338 is sponsored by Noema Pharma AG.

What drugs are being tested in NCT06019338?

Interventions in NCT06019338: Pain Diary use.

What condition does NCT06019338 study?

NCT06019338 studies Trigeminal Neuralgia.

Is NCT06019338 still recruiting?

NCT06019338 is currently completed. Last updated 10 December 2024.

Last reviewed 2024-12-10 · How we verify

NCT06019338

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Study to Validate a Pain Diary for Patient With Trigeminal Neuralgia

Completed Last updated 10 December 2024

What this trial tests

trial testing Pain Diary use in Trigeminal Neuralgia in 30 participants. Completed in 31 August 2023.

Timeline

20 November 2021

Primary endpoint
31 August 2023

31 August 2023

Quick facts

Lead sponsor	Noema Pharma AG
Status	Completed
Study type	OBSERVATIONAL
Enrollment	30
Start date	20 November 2021
Primary completion	31 August 2023
Estimated completion	31 August 2023
Sites	2 locations across United Kingdom, United States

Drugs / interventions tested

Pain Diary use

Conditions studied

Trigeminal Neuralgia — all drugs for Trigeminal Neuralgia →

Sponsor

Noema Pharma AG — full company profile →

Who can join

40 and older, any sex, with Trigeminal Neuralgia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the study is to establish the validity of a patient reported diary in TN . The following objectives have been identified: 1. To generate evidence to support diary content validity by performing qualitative research studies with TN patients and Healthcare Professionals (HCPs). 2. To provide further support to the diary, sensitivity to change, known groups validity (ability to differentiate between severity groups), and construct validity.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Abstracts from the 18 th European Headache Congress (EHC) : Rotterdam, The Netherlands. 4-7 December 2024.
· 2025 · cited 1× · PMID 40545525 · DOI 10.1186/s10194-025-02062-8
Qualitative validation of TnED©, an electronic instrument capturing pain dimensions in patients with trigeminal neuralgia.
Tahiri AS, Dodhia SA, Chotaliya S, Ansari H, et al · · 2026 · PMID 42220290 · DOI 10.22514/jofph.2026.038

Verify or expand the search:

Other recruiting trials for Trigeminal Neuralgia

Currently open trials in the same condition.

NCT07252453 — Comparison b/w Carbamazepine vs Oxcarbazepine in Treatment of Trigeminal Neuralgia · NA · active not recruiting
NCT06684275 — Comparison of Pulsed and Thermal Radiofrequency for Trigeminal Neuralgia · NA · recruiting
NCT06620172 — CT-guided vs Fluoroscopy-guided Trigeminal Ganglion Radiofrequency Thermocoagulation for Idiopathic Trigeminal Neuralgia · NA · recruiting
NCT06849219 — Comparison of Oxcarbazepine Versus Carbamazepine in the Management of Trigeminal Neuralgia · Phase 4 · active not recruiting
NCT06216886 — OnabotulinumtoxinA for Trigeminal Neuralgia · Phase 4 · recruiting

Other Noema Pharma AG trials

Trials by the same sponsor.

NCT06385795 — A Study of NOE-115 in Women With Vasomotor Symptoms Due to Menopause · Phase 2 · completed
NCT05583955 — A 10-week Efficacy Study of NOE-105 in Childhood Onset Fluency Disorder (Orpheus) · Phase 2 · completed
NCT05059327 — Basimglurant (NOE-101) in Children, Adolescents, and Young Adults With TSC · Phase 2 · completed
NCT05217628 — An Efficacy and Safety Study of Basimglurant (NOE-101) in Patients With Trigeminal Neuralgia. · Phase 2, PHASE3 · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06019338 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Noema Pharma AG
Last refreshed: 10 December 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06019338.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing